Save time and get answers to complex questions with AI chat
What's the advised delay for milk post lipitor?Mobic injection patent oehringer ingelheim france?Tracleer online pharmacy?Complera ingredients?Atorvastatin side effects heart palpitations?
See the DrugPatentWatch profile for keytruda
Keytruda (pembrolizumab) received its first U.S. FDA approval on May 13, 2014. This approval was for the treatment of metastatic or unresectable melanoma that had progressed after prior therapy.
Other Questions About Keytruda :